Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2373-8057
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease ; volume:8 ; number:1 ; day:21 ; month:10 ; year:2022 ; pages:1-8 ; date:12.2022
npj Parkinson's Disease ; 8, Heft 1 (21.10.2022), 1-8, 12.2022

Creator
Ben Bashat, Dafna
Thaler, Avner
Lerman Shacham, Hedva
Even-Sapir, Einat
Hutchison, Matthew
Evans, Karleyton C.
Orr-Urterger, Avi
Cedarbaum, Jesse M.
Droby, Amgad
Giladi, Nir
Mirelman, Anat
Artzi, Moran
Contributor
SpringerLink (Online service)

DOI
10.1038/s41531-022-00405-9
URN
urn:nbn:de:101:1-2023010709182744041334
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Ben Bashat, Dafna
  • Thaler, Avner
  • Lerman Shacham, Hedva
  • Even-Sapir, Einat
  • Hutchison, Matthew
  • Evans, Karleyton C.
  • Orr-Urterger, Avi
  • Cedarbaum, Jesse M.
  • Droby, Amgad
  • Giladi, Nir
  • Mirelman, Anat
  • Artzi, Moran
  • SpringerLink (Online service)

Other Objects (12)

Neuropathology of incidental Lewy body & prodromal Parkinson’s disease

Neuropathology of incidental Lewy body & prodromal Parkinson’s disease

A look back at the prodromal findings in Parkinson’s disease

A look back at the prodromal findings in Parkinson’s disease

Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram

Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram

Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned

Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned

Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease

Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease

Genetically-informed prediction of short-term Parkinson’s disease progression

Genetically-informed prediction of short-term Parkinson’s disease progression

Prodromal sensory neuropathy in Pink1-/-SNCAA53T double mutant Parkinson mice

Prodromal sensory neuropathy in Pink1-/-SNCAA53T double mutant Parkinson mice

Prodromal Parkinson's disease: hype or hope for disease-modification trials?

Prodromal Parkinson's disease: hype or hope for disease-modification trials?

Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease

Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease

Circadian re-set repairs long-COVID in a prodromal Parkinson’s parallel: a case series

Circadian re-set repairs long-COVID in a prodromal Parkinson’s parallel: a case series

Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease

Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease

A retrospective study of the MDS criteria for prodromal Parkinson’s disease in the general population

A retrospective study of the MDS criteria for prodromal Parkinson’s disease in the general population

Related objects